-
541
-
542
Systemic Therapy in Advanced Hepatocellular Carcinoma: Patient Selection and Key Considerations
Published 2022-11-01Subjects: “…hepatocellular carcinoma…”
Get full text
Article -
543
Puzzling out the role of MIAT LncRNA in hepatocellular carcinoma
Published 2024-06-01“…In the current review, the authors highlight the multifaceted role of myocardial infarction-associated transcript (MIAT), a well-known lncRNA, in hepatocellular carcinoma (HCC). Since its discovery, MIAT has been described as a regulator of carcinogenesis in several malignant tumors and its overexpression predicts poor prognosis in most of them. …”
Get full text
Article -
544
Diagnostic performance of US LI-RADS in hepatocellular carcinoma surveillance
Published 2023-08-01Subjects: “…Hepatocellular carcinoma…”
Get full text
Article -
545
Identification of serum glycobiomarkers for Hepatocellular Carcinoma using lectin microarrays
Published 2022-10-01Subjects: “…Hepatocellular carcinoma…”
Get full text
Article -
546
Identification reproducible microbiota biomarkers for the diagnosis of cirrhosis and hepatocellular carcinoma
Published 2023-03-01Subjects: Get full text
Article -
547
Pathogenesis of NAFLD-Related Hepatocellular Carcinoma: An Up-to-Date Review
Published 2023-03-01Subjects: Get full text
Article -
548
Early monocyte response following local ablation in hepatocellular carcinoma
Published 2022-10-01Subjects: “…hepatocellular carcinoma…”
Get full text
Article -
549
PAIP1 is a novel oncogene in human hepatocellular carcinoma
Published 2022-11-01Subjects: Get full text
Article -
550
Multicentric Fibrolamellar Hepatocellular Carcinoma: A Rare Case Report
Published 2023-01-01“…Multicentric fibrolamellar hepatocellular carcinoma has not been reported yet in the world as of our knowledge. …”
Get full text
Article -
551
Adherence to Tumor Board Recommendations in the Treatment of Patients with Hepatocellular Carcinoma
Published 2023-05-01“…Yueming Cao,1 Catherine Mezzacappa,1,2 Ariel Jaffe,1,2 Mario Strazzabosco,1,2 Tamar H Taddei1,2 1Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA; 2Department of Internal Medicine Digestive Disease Section, Yale School of Medicine, New Haven, CT, USACorrespondence: Tamar H Taddei, Department of Internal Medicine, Yale School of Medicine, PO Box 208019, New Haven, CT, 06520-8019, USA, Tel +1 203-785-7312, Fax +1 203-785-7273, Email tamar.taddei@yale.eduBackground: Hepatocellular carcinoma (HCC) is a heterogeneous disease that typically arises in the setting of chronic liver disease, making treatment selection complex. …”
Get full text
Article -
552
The investigation on the hypercoagulability of hepatocellular carcinoma‐related cerebral infarction with thromboelastography
Published 2023-04-01Subjects: Get full text
Article -
553
Hepatogastric Fistula following Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma
Published 2014-10-01Subjects: Get full text
Article -
554
Intratumoral bacteria interact with metabolites and genetic alterations in hepatocellular carcinoma
Published 2022-09-01Get full text
Article -
555
Phenotypic Characteristics of the Tumour Microenvironment in Primary and Secondary Hepatocellular Carcinoma
Published 2021-04-01Subjects: “…hepatocellular carcinoma…”
Get full text
Article -
556
Effect of Diphtheria Toxin-Based Gene Therapy for Hepatocellular Carcinoma
Published 2020-02-01Subjects: “…hepatocellular carcinoma…”
Get full text
Article -
557
Aberrant Lipid Metabolism in Hepatocellular Carcinoma Revealed by Liver Lipidomics
Published 2017-11-01“…Background: The aim of this study was to characterize the disorder of lipid metabolism in hepatocellular carcinoma (HCC). HCC is a worldwide disease. …”
Get full text
Article -
558
Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages
Published 2022-05-01“…Proteogenomic analyses of hepatocellular carcinomas (HCC) have focused on early-stage, HBV-associated tumours and lacked information about the phosphoproteome. …”
Get full text
Article -
559
Association of elevated autoantibody to high expression of GNAS in hepatocellular carcinoma
Published 2023-12-01“…Purpose: This study was based on hepatocellular carcinoma (HCC) patients of early-stage to explore the diagnostic capability and possible production causes of anti-GNAS autoantibody. …”
Get full text
Article -
560
Interleukin-6 in Hepatocellular Carcinoma: A Dualistic Point of View
Published 2023-09-01Subjects: “…hepatocellular carcinoma…”
Get full text
Article